๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II evaluation of echinomycin (NSC-526417) in patients with central nervous system malignancies

โœ Scribed by Sarah A. Taylor; John Crowley; Jennette Townsend; F. Stephen Vogel; Harmon Eyre; James J. Braun; John Wendall Goodwin

Publisher
Springer US
Year
1993
Tongue
English
Weight
298 KB
Volume
15
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II evaluation of fludarabine phosp
Phase II evaluation of fludarabine phosphate in patients with central nervous system tumors
โœ Sarah A. Taylor; John Crowley; F. Stephen Vogel; Jeannette J. Townsend; Harmon J ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer US ๐ŸŒ English โš– 147 KB

Twenty-three patients with malignant central nervous system tumors were treated with fludarabine phosphate (2-FAMP) on a 5 day bolus schedule. One brief partial response was observed in 20 malignant astrocytoma patients. 2FAMP as given in this protocol is inactive in previously treated patients with

Phase II study of high-dose tamoxifen (N
Phase II study of high-dose tamoxifen (NSC-180973) in patients with disseminated malignant melanoma
โœ Edward T. Creagan; James N. Ingle; David L. Ahmann; Stephanie J. Green ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 206 KB ๐Ÿ‘ 3 views

Seventeen patients with disseminated malignant melanoma received a daily oral regimen of tamoxifen, 100 mg/m2. All patients had prior chemotherapy and predominantly visceral involvement. None of the patients had an objective regression and most (71%) had progressive disease at the time of first reas